HDL
9
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (9)
Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles
Functional Yogurt Consumption and Its Effects on the Lipid Profile of Healthy Subjects
Oral Nutritional Supplement Effect on HDL Function
Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.
Is Monocyte/HDL Ratio a Predictor of Mortality in Aortic Valve Surgery
HDL Function Dietary Supplement Safety and QOL
Effects of Short-term Diet on HDL Composition and Function
Comparing a Low-GI Nutrigenetic and Ketogenic Diet for Weight Loss With 18 Month Follow-up
Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)